The molecular landscape of osteosarcoma is complex, with receptor tyrosine kinases (RTKs) such as IGF-1R, PDGFR, and HER2 playing pivotal roles in tumor growth and progression. The gene discussed is ERBB2; the disease is osteosarcoma.